Series B - MyoKardia
Investment Firm
Overview
MyoKardia is a clinical-stage biopharmaceutical company that develops targeted therapies for the treatment of rare cardiovascular diseases.
Announced Date
Apr 30, 2015
Funding Type
Series B
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
4
Round Details and Background
MyoKardia raised $46000000 on 2015-04-30 in Series B
MyoKardia is a clinical-stage biopharmaceutical company that develops targeted therapies for the treatment of rare cardiovascular diseases.
Company Funding History
5
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Apr 30, 2015 |  Series B - MyoKardia | 5 | - | 46.0M |
| Aug 22, 2014 | Venture Round - MyoKardia | 6 | - | 10.0M |
| Oct 04, 2012 | Venture Round - MyoKardia | - | 4.0M | |
| Sep 20, 2012 | Series A - MyoKardia | 1 | - | 38.0M |
Recent Activity
There is no recent news or activity for this profile.